First Manhattan’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-39
| Closed | -$4.66K | – | 1641 |
|
|
2022
Q4 | $4.66K | Buy |
+39
| New | +$4.66K | ﹤0.01% | 1416 |
|
|
2021
Q3 | – | Sell |
-29
| Closed | -$2K | – | 1651 |
|
|
2021
Q2 | $2K | Buy |
+29
| New | +$2K | ﹤0.01% | 1504 |
|
|
2015
Q4 | – | Sell |
-41,305
| Closed | -$1.64M | – | 1462 |
|
|
2015
Q3 | $1.64M | Sell |
41,305
-111,000
| -73% | -$4.42M | 0.01% | 358 |
|
|
2015
Q2 | $7.27M | Sell |
152,305
-10,100
| -6% | -$482K | 0.04% | 205 |
|
|
2015
Q1 | $6.45M | Sell |
162,405
-80,700
| -33% | -$3.2M | 0.04% | 225 |
|
|
2014
Q4 | $5.43M | Hold |
243,105
| – | – | 0.03% | 243 |
|
|
2014
Q3 | $3.81M | Buy |
243,105
+220,592
| +980% | +$3.46M | 0.02% | 274 |
|
|
2014
Q2 | $333K | Buy |
+22,513
| New | +$333K | ﹤0.01% | 593 |
|